Preoperative screening: The rationale of measuring APTT in risk assessment [8]

Haematologica

Volumn 86, Issue 3, 2001, Pages 328-

  Lippi, G ^a   Franchini, M ^a   Brazzarola, P ^a   Manzato, F ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

APTT; Preoperative screening; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; LUPUS ANTICOAGULANT; VON WILLEBRAND FACTOR;

BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; HEMATOLOGICAL PARAMETERS; HUMAN; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE EVALUATION; RISK ASSESSMENT; SCREENING TEST; SURGICAL PATIENT; THROMBIN TIME;

BLOOD LOSS, SURGICAL; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE CARE; RISK FACTORS;

EID: 0035071855     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Preoperative laboratory testing: Should any tests be "routine" before surgery?
2. Preoperative hemostatic evaluation: Which tests, if any?
3. How well does the activated partial thromboplastin time predict postoperative hemorrhage?
4. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: Problems and possible solutions
5. Disorders of plasma clotting factors
6. Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency
7. Rare coagulation disorders